Eisai Co., Ltd. ESAIY
Set alert
7.89 USD -0.06 -0.75%
As of Nov 2, 3:55 PM ET
7.86 Day range 7.90
5.69 52-week range 8.58
- YTD
- +6.91%
- 1 year
- +7.79%
- Open
- 7.88
- Prev close
- 7.95
- Mkt cap
- 8.91B
- Vol
- 15.14K
- Avg vol
- 59.19K
- EPS
- 0.23
- P/E
- 34.30
More statistics
- Low
- 7.86
- High
- 7.90
2Y chart
Events in this range
- Feb 3, 2025Earnings: 0.00088; estimate —; surprise —%
- Mar 31, 2025Dividend: 0.13877
- May 12, 2025Earnings: 0.00536; estimate —; surprise —%
- Jul 30, 2025Earnings: 0.08996; estimate 0.05949; surprise 51.22%
- Sep 30, 2025Dividend: 0.12868
- Nov 5, 2025Earnings: 0.06102; estimate —; surprise —%
- Feb 4, 2026Earnings: 0.09889; estimate —; surprise —%
- Mar 30, 2026Dividend: 0.50132
- Mar 31, 2026Dividend: 0.12517
- May 12, 2026Earnings: -0.0184; estimate —; surprise —%
- Sep 29, 2026Dividend: 0.095625
Signals (109)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 19, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 2, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 16, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 6, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 3 months ago |
| SMA: Bullish | Jul 28, 2026 | 3 months ago |
| RSI: Overbought | Jul 24, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 12, 2026 | 4 months ago |
| RSI: Oversold | May 20, 2026 | 5 months ago |
| MACD: Sell Signal | May 15, 2026 | 5 months ago |
| MACD: Buy Signal | May 6, 2026 | 6 months ago |
| SMA: Bearish | Apr 21, 2026 | 6 months ago |
Newest 20 of 109.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 12, 2026 | Mar 31, 2026 | — | -0.0184 | — | — |
| Feb 4, 2026 | Dec 31, 2025 | — | 0.09889 | — | — |
| Nov 5, 2025 | Sep 30, 2025 | — | 0.06102 | — | — |
| Jul 30, 2025 | Jun 30, 2025 | 0.05949 | 0.08996 | +0.03 | +51.22% |
| May 12, 2025 | Mar 31, 2025 | — | 0.00536 | — | — |
| Feb 3, 2025 | Dec 31, 2024 | — | 0.00088 | — | — |
News
- Eisai Co., Ltd. (ESAIY) Q1 2027 Earnings Call Transcript
- FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug
- Eisai Co., Ltd. (ESAIY) Analyst/Investor Day Transcript
- Eisai Co., Ltd. (ESAIY) Q4 2026 Earnings Call Transcript
- Merck-Eisai's combination cancer therapy fails to meet main goals of late-stage study
- These Alzheimer's drugs were supposed to revolutionize the way we fight the disease. The reality is more complicated.
- Eisai to Present the Latest Data on Real-World Treatment with Lecanemab and Supporting a Standardized Framework for Treating Early Alzheimer's Disease at the 78th American Academy of Neurology's Annual Meeting
- Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency
- Eisai Co., Ltd. (ESAIY) Q3 2026 Earnings Call Transcript
- Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle
Your note
Sign in to keep a note on ESAIY — it syncs with the Stock Master app.